{"pub": "thehill", "url": "https://thehill.com/policy/healthcare/public-global-health/465938-three-drug-distributors-in-talks-for-18-billion-opioid", "downloaded_at": "2019-10-15 23:09:11.640810+00:00", "title": "Three drug distributors in talks for $18 billion opioid settlement: report", "language": "en", "text": "Three of the largest drug distributors in the U.S. are in the process of finalizing a settlement that would have them collectively pay $18 billion over 18 years for their role in the opioid epidemic, The Wall Street Journal reported.\n\nMcKesson, AmerisourceBergen and Cardinal Health are three of the entities targeted in more than 2,000 lawsuits filed by cities, counties and states that allege the pharmaceutical industry's marketing practices helped fuel an epidemic that has claimed 400,000 lives and left communities grappling with the costs of addiction.\n\nADVERTISEMENT\n\nThe goal of the lawsuits is to reclaim the cost of the damage that opioids have done to countless communities.\n\nPressure is mounting for McKesson, AmerisourceBergen and Cardinal Health, as all three are set to begin trial in a Cleveland federal court on Monday, according to the Journal.\n\nBy the end of it, the deal could include other drug companies, such as Johnson & Johnson, as well as the donation of opioid addiction treatment medicine.\n\nPurdue Pharma, maker of OxyContin, filed for bankruptcy in September in the hope of reaching a settlement between $10 and $12 billion.\n\nFor the plan to be finalized, however, support must be gathered from lawyers of the plaintiffs and various government entities.", "description": "Three of the largest drug distributors in the U.S.", "authors": [], "top_image": "https://thehill.com/sites/default/files/prescription_drugs_pharmacy_20180910getty.jpg", "published_at": "2019-10-15"}